Company Data

Merus N.V.

Ticker
MRUS
Current Price
$42.27 5.15%
Market Cap
$2.9B
Price Target
Refer to Report
Volume
925.4K
52wk Range
$37.77 - $61.61
Advanced Market Data

Overview

Merus NV is a clinical-stage immuno-oncology company. It develops bispecific antibody therapeutics. The company is developing innovative full-length human bispecific antibody therapeutics, referred to as Biclonics. Merus operates in one reportable segment, which comprises the discovery and development of innovative bispecific therapeutics.

Inbox Intel from Channelchek.

Informed investors make more money. And it’s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy